Dr. Reddy's Laboratories Grants Stock Options Under Employee Scheme
The Nomination, Governance and Compensation Committee of the Board of Directors of Dr. Reddy's Laboratories Limited has approved the grant of stock options to an eligible employee. This decision was made via a resolution by circulation dated July 22, 2026, concerning the Employees Stock Option Schemes of the Company.The grant is executed under the Dr. Reddy's Employees Stock Option Scheme, 2018. The Committee approval relates to the granting of Indian Stock Options to the eligible employee as part of the company’s employee benefit program.
Key details regarding the stock option grant include:
| Feature | Details |
|---|---|
| Type of Option(s) | Indian Stock Options |
| Number of options granted | 15,933 |
| Exercise Price per share | Rs. 1,206/- |
| Scheme Name | Dr. Reddy's Employees Stock Option Scheme, 2018 |
The grant is subject to the terms of the Dr. Reddy's Employees Stock Option Scheme, 2018, which is administered and implemented by the Nomination, Governance & Compensation Committee. The options granted have a vesting schedule stipulating 100% vesting at the end of three years.
DRREDDY Stock Price Movement
Dr. Reddy's Laboratories Limited shed value on Wednesday, with shares closing at ₹1182.80 after slipping 2.16% from previous trading levels. The stock accounted for approximately 2.53 million shares of volume and traded within a daily range bounded by ₹1169 and ₹1202.3.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.